Department of Urology, University of Florence, Florence, Italy.
Eur Urol. 2009 Jul;56(1):142-8. doi: 10.1016/j.eururo.2008.01.088. Epub 2008 Feb 8.
Controversial data on modifications of prostate size, function and disease of spinal cord injury (SCI) patients has been previously reported.
An analytical observational cohort study on male SCI patients was planned in order to evaluate prostate gland growth, including benign prostatic hyperplasia in relation to the age of the patient at SCI onset. Additional evaluations considered hormonal and biochemical parameters and prostate cancer.
DESIGN, SETTING AND PARTICIPANTS: 113 SCI patients (mean age 61.3) and 109 age-matched able bodied subjects (mean age 65.4) were enrolled and stratified according to the patient age at SCI onset (< or = 30, 31-49, and > or = 50 years).
A complete medical history was then collected from all SCI patients and able bodied subjects.
Total prostate antigen (PSA) and testosterone (T) serum levels and urine culture were collected. Digital rectal examination and transrectal ultrasonography were performed.
Patients with SCI showed PSA value and prostate size significantly lower than those observed in able bodied subjects, and an inverse relationship was observed in SCI patients between these two parameters and patient age at the time of lesion onset. T serum levels were lower in SCI patients when compared to able bodied subjects. No SCI patient presented prostate cancer, while 9.7% of control subjects were affected by prostate cancer.
Prostate volume and PSA levels are lower in SCI patients and are inversely related to the patient age at lesion onset. Whether this effect is mediated directly or indirectly by a impaired nerve supply to the prostate remains to be determined. Despite the present observation of reduced prostate disease, as during the last twenty years life expectancy in SCI patients has improved significantly, the need to screen these patients for the occurrence of prostate disease should not be disregarded.
先前已有报告称,有关脊髓损伤(SCI)患者前列腺大小、功能和疾病改变的数据存在争议。
计划对男性 SCI 患者进行一项分析性观察队列研究,以评估前列腺腺体的生长情况,包括与 SCI 发病时患者年龄相关的良性前列腺增生。另外还评估了激素和生化参数以及前列腺癌。
设计、设置和参与者:共纳入 113 例 SCI 患者(平均年龄 61.3 岁)和 109 例年龄匹配的健康对照组(平均年龄 65.4 岁),并根据患者 SCI 发病时的年龄进行分层(≤30 岁、31-49 岁和≥50 岁)。
然后从所有 SCI 患者和健康对照组中收集完整的病史。
采集所有 SCI 患者和健康对照组的总前列腺抗原(PSA)和睾酮(T)血清水平及尿培养。进行直肠指检和经直肠超声检查。
与健康对照组相比,SCI 患者的 PSA 值和前列腺体积明显较低,并且在 SCI 患者中,这两个参数与发病时的患者年龄呈负相关。与健康对照组相比,SCI 患者的 T 血清水平较低。没有 SCI 患者患有前列腺癌,而对照组中有 9.7%的人患有前列腺癌。
SCI 患者的前列腺体积和 PSA 水平较低,且与发病时的患者年龄呈负相关。这种影响是通过受损的前列腺神经供应直接或间接介导的,还有待确定。尽管目前观察到 SCI 患者的前列腺疾病减少,但由于过去二十年来 SCI 患者的预期寿命显著提高,仍不应忽视对这些患者进行前列腺疾病筛查的必要性。